NASDAQ$ZYXIQ
Zynex Inc · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
Zynex's second quarter results for 2024 were reported, showing an 11% increase in revenue to $49.9 million.
Zynex reported an 11% increase in revenue for Q2 2024, reaching $49.9 million, driven by a 20% growth in device orders. However, revenue was below previous guidance due to a reduction in sales representatives and a changing product mix. Net income was $1.2 million, with diluted EPS of $0.04.
- Q2 2024 orders increased 20% year-over-year, the highest number of orders in Company history for the ninth consecutive quarter.
- Q2 2024 revenue increased 11% year-over-year to $49.9 million, but was lower than previous guidance of $52.0 million.
- Q2 2024 net income was $1.2 million, with diluted EPS of $0.04.
- The company repurchased $2.2 million of its common stock in Q2 2024.
Headline financials
Revenue & EPS history
Zynex · Revenue · Quarterly
$49.9M
Revenue by segment
Zynex · $49.9M total across 2 segments · Q3 2023
- Supplies$33.1M—66.2%
- Devices$16.9M—33.8%
Forward guidance
Zynex anticipates third quarter 2024 revenue to be at least $50.0 million and diluted EPS to be at least $0.05. The Company now expects 2024 net revenue of at least $200 million, a 9% increase from 2023. Diluted EPS is expected to be at least $0.20 per share.
Tailwinds
- Third quarter 2024 revenue is estimated to be at least $50.0 million.
- Third quarter Diluted EPS is estimated to be at least $0.05.
- The Company expects 2024 net revenue of at least $200 million, a 9% increase from 2023.
- Diluted EPS is expected to be at least $0.20 per share.
- Company is focusing on diversifying revenue streams with innovative new products.
Headwinds
- Revenue during the quarter was impacted by a continued change in product mix.
- Sales of private labeled pain management products growing more than anticipated are one-time and lack the trailing revenue model.
- Company continued its focus on sales rep productivity and separated more underperforming reps than initially anticipated.
- The separation of underperforming reps decreases near-term revenue.
- With the change in product mix and sales force reduction, the company is revising guidance down for the year.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q2 2024
+0.4%
Avg return
Earnings day
-1.8%
Avg return
5 days after
-6.5%
Avg return
30 days after
46%
29 / 63 earnings
Positive
+38.5%
Q3 2014
Best reaction
-51.6%
Q1 2010
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2024 | -51.3% | — | — | |
| Q3 2025 | +0.0% | +0.0% | -98.2% | |
| Q2 2025 | +0.0% | +0.0% | +0.0% | |
| Q1 2025 | -25.6% | +0.0% | +0.0% | |
| Q3 2024 | +9.1% | +0.0% | +0.0% | |
| Q2 2024 | -11.4% | +0.0% | +0.0% | |
| Q1 2024 | +2.8% | +0.0% | +0.0% | |
| Q4 2023 | -8.8% | +0.0% | +0.0% | |
| Q3 2023 | +17.5% | +0.0% | +0.0% | |
| Q2 2023 | +3.3% | +0.0% | +0.0% | |
| Q1 2023 | +2.5% | +0.0% | +0.0% | |
| Q4 2022 | +16.7% | +0.0% | +0.0% | |
| Q3 2022 | +15.0% | +0.0% | +0.0% | |
| Q2 2022 | +13.3% | +0.0% | +0.0% | |
| Q1 2022 | -8.6% | +0.0% | +0.0% | |
| Q4 2021 | -1.7% | +0.0% | +0.0% | |
| Q3 2021 | +10.0% | +0.0% | +0.0% | |
| Q2 2021 | -19.3% | +0.0% | +0.0% | |
| Q1 2021 | -9.2% | -12.0% | -6.3% | |
| Q4 2020 | -21.2% | -22.4% | -18.8% | |
| Q3 2020 | -6.5% | — | — | |
| Q2 2020 | -6.0% | — | — | |
| Q1 2020 | -1.1% | — | — | |
| Q4 2019 | +3.1% | — | — | |
| Q3 2019 | -7.9% | — | — | |
| Q2 2019 | +9.8% | — | — | |
| Q1 2019 | +7.9% | — | — | |
| Q4 2018 | -11.1% | — | — | |
| Q3 2018 | +3.4% | — | — | |
| Q2 2018 | -3.3% | — | — | |
| Q1 2018 | +4.5% | — | — | |
| Q4 2017 | -20.7% | — | — | |
| Q3 2017 | +6.6% | — | — | |
| Q2 2017 | +34.6% | — | — | |
| Q1 2017 | -5.6% | — | — | |
| Q4 2016 | +9.7% | — | — | |
| Q3 2016 | +23.1% | — | — | |
| Q2 2016 | +34.8% | — | — | |
| Q1 2016 | +0.0% | — | — | |
| Q4 2015 | +0.0% | — | — | |
| Q3 2015 | -4.3% | — | — | |
| Q2 2015 | -5.4% | — | — | |
| Q4 2014 | +0.0% | — | — | |
| Q1 2015 | +0.0% | — | — | |
| Q3 2014 | +38.5% | — | — | |
| Q2 2014 | +2.2% | — | — | |
| Q1 2014 | -0.2% | — | — | |
| Q4 2013 | -3.6% | — | — | |
| Q3 2013 | +13.6% | — | — | |
| Q2 2013 | +7.1% | — | — | |
| Q1 2013 | +0.0% | — | — | |
| Q4 2012 | +3.4% | — | — | |
| Q3 2012 | +5.6% | — | — | |
| Q2 2012 | -5.1% | — | — | |
| Q1 2012 | -6.3% | — | — | |
| Q4 2011 | +0.0% | — | — | |
| Q3 2010 | +12.9% | — | — | |
| Q3 2011 | +12.9% | — | — | |
| Q2 2011 | +1.1% | — | — | |
| Q1 2011 | -8.2% | — | — | |
| Q4 2010 | +0.0% | — | — | |
| Q2 2010 | +2.0% | — | — | |
| Q1 2010 | -51.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro